• Amerigo Scientific Launches Ultra Low Temperature Freezers (-40°C to -86°C) for Lab Sample Storage

    Jun 20, 2023, 10:57 by
    Amerigo Scientific launches its ultra-low temperature freezers with a temperature range from -40°C to -86°C.
    Full story
  • CluePoints, Ken Getz & Tufts CSDD and PwC Unveil New RBQM Insights Report at DIA Global Annual Meeting 2023

    Jun 20, 2023, 10:57 by
    CluePoints, Ken Getz & Tufts CSDD and PwC Unveil New RBQM Insights Report at DIA Global Annual Meeting 2023 CluePoints and partners present and discuss the results of a new study examining RBQM use and adoption.
    Full story
  • Alfa Chemistry Commenced Offering Nonlinear Crystals and Precision Optical Materials

    Jun 20, 2023, 10:57 by
    Full story
  • Huateng Pharma Announced To Attend INTERPEHX Week Tokyo - in-PHARMA JAPAN In July 2023

    Jun 20, 2023, 10:57 by
    Huateng Pharma is a leading and professional manufacturer which can provide pharmaceutical intermediates, PEG derivatives, biochemical reagents, APIs, Vitamin D Derivatives and so on. We have a 34,000 square meter manufacturing site with advanced design concept of intelligent manufacturing, which can realize the integration of the production process and accomplish the complete transformation of lab scale - pilot plant - large-scale commercial production, with an annual capacity of more than 1 billion RMB.
    Full story
  • Alfa Chemistry: Test Kits Provides New Options to Transform Testing Strategy

    Jun 16, 2023, 11:09 by
    Full story
  • Packaging Solutions Ensuring Product Integrity: Glass and Plastic Varieties

    Jun 16, 2023, 11:09 by
    Full story
  • Creative Proteomics Expands Proteomics Services with Launch of N-Terminal Edman Degradation Service

    Jun 16, 2023, 10:08 by
    Full story
  • Creative Proteomics Launches Crotonylation Proteomics Analysis Service to Enhance Your Epigenetic Research

    Jun 16, 2023, 10:08 by
    Full story
  • Creative Proteomics Revolutionizes DNA-Protein Interaction Studies with Cutting-Edge DNA Pull Down Service

    Jun 16, 2023, 10:08 by
    Full story
  • Creative Biolabs' Exhibition at BIO 2023 Accomplished

    Jun 16, 2023, 09:58 by
    Creative Biolabs released exhibition highlight moments from their booth 2548 at the 2023 BIO International Convention held from June 5 to 8.
    Full story
  • Rescuing a Study in Jeopardy with Comprehensive Clinical Adjudication

    Jun 16, 2023, 01:00 by User Not Found
    Clinical Research News | Global clinical trial programs are complex, often encompassing dozens of studies for increasingly uncommon indications. Sponsors of these programs are wisely seeking out independent adjudication of clinical events, or endpoints, that occur over the course of the trial to ensure patient safety and the efficacy of drugs and devices. While endpoint adjudication is not required by regulatory bodies, it can deliver valuable insights during a trial and lend strong, unbiased support for approvals down the road.
    Full story
  • PrecisionLife Announces Strategic CNS Drug Development Collaboration with Nanopharmaceutics

    Jun 15, 2023, 09:48 by
    PrecisionLife and Nanopharmaceutics, Inc. has announced today a strategic collaboration aiming to accelerate and de-risk the development of Nanopharmaceutics’ portfolio of central nervous system assets.
    Full story
  • BullFrog AI Strengthens Capabilities of its AI Platform through Expansion of Licensing Agreement with Johns Hopkins Applied Physics Laboratory

    Jun 15, 2023, 09:48 by
    BullFrog AI Holdings, Inc. announced the expansion of its worldwide license agreement with the Johns Hopkins Applied Physics Laboratory (APL), in Laurel, Maryland, for use of patented technology powering the Company’s bfLEAP™ platform, an AI-driven platform for analyzing drug development data to potentially make life-saving therapies and treatments available to patients more quickly.
    Full story
  • MIB Agents’ Community of Families Has Awarded Over $1.5M in Grants to Research Pediatric Bone Cancer

    Jun 15, 2023, 09:48 by
    MIB Agents, a leading pediatric osteosarcoma nonprofit dedicated to Making It Better for its community of patients, caregivers, doctors, and researchers, announced today that since its inception in 2016, it has awarded over $1.5 million to scientists across the country through its OutSmarting Osteosarcoma grant program. The OutSmarting Osteosarcoma grants are supported by MIB Agents Family Funds, osteosarcoma patients and families who raise funds in honor of an OsteoWarrior, a patient currently battling osteosarcoma or an OsteoAngel, a loved one who has passed.
    Full story
  • AntlerA Norrin/Wnt-agonist ANT antibody enters clinical trials through a strategic partnership with EyeBio

    Jun 15, 2023, 09:48 by
    AntlerA Therapeutics has announced a strategic collaboration and licensing agreement with EyeBio to begin clinical testing of AntlerA's Norrin/Wnt-agonist, a treatment of leaky blood vessels in the eye.
    Full story
  • Breaking Barriers in Clinical Trials: AI and Automation as a Catalyst for Innovation

    Jun 15, 2023, 09:48 by
    This article highlights how AI and automation are driving innovation in clinical trial research by improving patient outcomes, reducing costs, and overcoming traditional barriers to progress.
    Full story
  • SMi discloses £6 million seed funding round, bolsters team with new C-suite hire

    Jun 14, 2023, 10:33 by
    SMi Systems has disclosed a £6m seed funding round to develop and prove the utility of a novel multi-omic platform for in vitro diagnosis and biomedical research.
    Full story
  • Unique molecule life cycle platform released: Torx® 2.0

    Jun 14, 2023, 10:33 by
    Torx ® Software Limited, a collaboration between Cresset and Elixir Software, has launched a new ground-breaking platform for small molecule discovery chemistry.
    Full story
  • N-Lorem Foundation Bringing Real Hope To ‘N-Of-1’ Patients

    Jun 14, 2023, 01:00 by User Not Found
    Clinical Research News | Stanley T. Crooke, M.D., Ph.D., founder and longtime leader of the company that pioneered RNA-targeted therapeutics, is now chairman and CEO of the n-Lorem Foundation descaling the technology to treat patients helpless before a healthcare system that wasn’t built for “n-of-1” problems. He will be addressing a room of physicians and scientists tomorrow on the campus of Vanderbilt University.
    Full story
  • Inizio Prioritizes Medical Excellence and Transformation with New Senior Appointment

    Jun 13, 2023, 13:02 by
    Inizio Medical has announced a top-level hire in its senior leadership team, with the appointment of Shauna Aherne as President of Medical Excellence, Specialized Services.
    Full story
  • «
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77 (current)
  • 78
  • 79
  • 80
  • »